PR Newswire (Wed, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
746 people get VAR articles and Market Currents by email alert.
Get email alerts on VAR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (Apr 29, 2013)
-
PR Newswire (Apr 24, 2013)
-
PR Newswire (Mar 28, 2013)
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Why Varian's Shares Are Appropriately ValuedValuentum • Thu, Jun 7, 2012
-
Varian Medical: Earnings PreviewZacks Investment Research • Wed, Apr 25, 2012
-
Varian Medical Systems: A Good Long-Term Growth Play?Tactical Investor • Wed, Mar 28, 2012
-
Varian Medical: An Exciting OptionIntrinsic Valuation • Fri, Mar 2, 2012
-
Why I Bought Varian Medical SystemsJim Van Meerten • Fri, Dec 2, 2011
-
Varian Looks Fairly Valued At PresentValuentum • Mon, Oct 3, 2011
-
Varian Medical Earnings PreviewZacks Investment Research • Tue, Jul 26, 2011
-
Earnings Preview: Varian MedicalZacks Investment Research • Tue, Apr 26, 2011
-
Earnings Scorecard: Varian Medical SystemsZacks Investment Research • Thu, Feb 10, 2011
-
Varian Medical Systems: Earnings PreviewZacks Investment Research • Mon, Jan 24, 2011
-
Varian Medical Systems: Earnings PreviewZacks Investment Research • Wed, Oct 27, 2010
-
Varian Poised for Rebound - Barron'sSA Editor Susan Lerner • Sun, Oct 21, 2007
-
2 Cancer-Based Biotech Firms With Great Upside PotentialMatt Schilling • Mon, Oct 29, 2012
-
VIX - Options Volatility Sonar: Friday RecapErick McKitterick • Fri, Oct 26, 2012
-
The 6 Best Seasonal Large Cap Healthcare Stocks To Own Through NovemberTodd Campbell • Tue, Sep 11, 2012
-
Varian Medical Systems' CEO Hosts Investor Mid-Year Review (Transcript)Fri, May 11, 2012 • 1 Comment
-
Varian Medical Systems Inc. - Shareholder/Analyst CallFri, Feb 10, 2012
-
Varian Medical Systems Inc. - Shareholder/Analyst CallThu, Nov 3, 2011
-
Varian Medical Systems Inc. - Shareholder/Analyst CallTue, Oct 4, 2011
-
PR Newswire (Wed, 8:00AM)
-
PR Newswire (Apr 29, 2013)
-
at MarketWatch.com (Apr 25, 2013)
-
at MarketWatch.com (Apr 24, 2013)
-
at CNBC.com (Apr 24, 2013)
-
PR Newswire (Apr 24, 2013)
-
PR Newswire (Mar 28, 2013)
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
-
PR Newswire (Feb 11, 2013)
-
at MarketWatch.com (Jan 24, 2013)
VAR vs. ETF Alternatives
Company Description
We, Varian Medical Systems, Inc., are a Delaware corporation and were originally incorporated in 1948 as Varian Associates, Inc. In 1999, we transferred our instruments business to Varian, Inc. (“VI”), a wholly owned subsidiary, and transferred our semiconductor equipment business to Varian... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 22, 2:38 PM Varian Medical (VAR -1.5%) says it's received FDA 501(k) clearance for its Nexus DRF Digital X-Ray Imaging System, a diagnostic X-ray imaging processing workstation that combines radio frequency and digital radiography. Comment! [Healthcare]
- Wednesday, April 24, 4:47 PM More on Varian Medical (VAR): FQ2 comes in line on EPS but beats on revenue as total sales climbed 7% Y/Y. Net earnings rose 4.6% on broad sales growth, with its oncology segment sales improving 3% and x-ray products segment sales increasing 14%. Gross margin rose to 41.6% from 41.2%. The company cuts guidance for Q3 now saying it expects to earn an EPS of $0.98 - $1.02, versus $1.05 estimated by analysts. Shares -4.9% AH. Comment! [Healthcare, Earnings, On the Move]
- Wednesday, April 24, 4:14 PM Varian Medical (VAR): FQ2 EPS of $1.02 (incl. restructuring charges) in-line. Revenue of $768M (+7% Y/Y) beats by $9.98M. Shares -1.3% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Friday, April 19, 3:10 PM Varian (VAR +0.5%) says it's entered into a new collaboration with the Switzerland-based Paul Scherrer Institute to further advance motion techniques for proton therapy. The treatment uses a controlled, 4-D beam of protons to target tumors with higher levels of precision than other forms of radiation therapy, and can potentially limit collateral damage to healthy surrounding tissue. Comment! [Healthcare, Global & FX]
- Monday, April 15, 12:33 PM Varian Medical (VAR -5%) slides on a downgrade earlier today from Morgan Stanley to Underweight. The firm cites number of catalysts, including; accelerated purchases from customer for its oncology software products in FY12 making comps tough for FY13, heavy competition in the space from Elekta's Versa and Accuray's Tomo, a second round of U.S. reimbursement cuts impacting payments to freestanding clinics and fading large equipment trends in the U.S. and Europe. 2 Comments [Healthcare, On the Move]
- Thursday, March 7, 1:10 PM Varian Medical Systems (VAR +0.6%) gets a boost from an upgrade to Neutral at Goldman Sachs this morning. Goldman says its sell thesis on the stock has largely played out, and business fundamentals are stabilizing and consensus estimates now look reasonable. The firm also raises its price target from $62 to $79. Comment! [Healthcare]
- Wednesday, January 23, 5:34 PM More on Varian Medical Systems (VAR): Q1 comes in mixed, missing on the bottom line but beating on revenue. Oncology Systems and X-Ray Products businesses both grew 8% and 18% respectively Y/Y, with margins in line with expectations. The company lowers guidance for Q2 and FY13 however, now expecting Q2 EPS to be $0.98 - $1.03, versus the consensus of $1.04. For FY13, it anticipates EPS of $4.08 - $4.16. The Street view is for an EPS of $4.24. Shares -4.3% AH. Comment! [Healthcare, Earnings, On the Move]
- Wednesday, January 23, 4:11 PM Varian Medical (VAR): FQ1 EPS of $0.86 misses by $0.01. Revenue of $678M (+8% Y/Y) beats by $1.85M. Shares -3.6% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Wednesday, January 23, 12:05 AM Notable earnings after Wednesday’s close: AAPL, ALTR, AMGN, BKW, CBST, CCI, FBC, FFIV, HXL, INVN, JEC, LOGI, LRCX, LSI, MIPS, MLNX, NE, NFLX, PLCM, SWFT, SNDK, SYK, SYMC, TER, URI, VAR, WDC Comment! [Earnings]
- Tuesday, January 22, 5:35 PM Notable earnings after Wednesday’s close: AAPL, ALTR, AMGN, BKW, CBST, CCI, FBC, FFIV, HXL, INVN, JEC, LOGI, LRCX, LSI, MIPS, MLNX, NE, NFLX, PLCM, SWFT, SNDK, SYK, SYMC, TER, URI, VAR, WDC 3 Comments [Earnings]
- Friday, October 26, 2012, 12:45 PM Midday top 10 gainers: DV +25%. AMCC +24%. RCON +21%. TASR +18%. NEU +17%. STMP +16%. VAR +16%. ELMD +14%. N +14%. TSYS +15%. Midday top 10 Losers: CBRX -42%. CTCT -26%. MXWL -23%. HMSY -21%. VRSN -19%. REDF -16%. DECK -18%. UQM -17%. IPCM -16%. BJRI -15%. Comment! [On the Move]
- Friday, October 26, 2012, 12:35 PM Varian Medical Systems (VAR +15.4%) pops after beating on its FQ4 result late yesterday. Net earnings jumped 19% Y/Y on better oncology systems and X-ray product sales. The company also offered upbeat revenue guidance for the new fiscal year and current quarter. For both 2013 and the first quarter, the company says revenue could increase 8% to 9%. Analysts had projected FY revenue growth of 7% and FQ1 revenue growth of 6% respectively. Comment! [Healthcare, Earnings, On the Move]
- Thursday, October 25, 2012, 4:16 PM Varian Medical Systems (VAR): Q3 EPS of $1.08 beats by $0.05. Revenue of $756M (+5% Y/Y) beats by $9M. Shares +8.1% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
- Thursday, October 25, 2012, 12:10 AM Notable earnings after Thursday’s close: AAPL, AMZN, APKT, BAS, BMRN, CA, CB, CERN, CINF, CLD, CLWR, COG, CRBC, CSTR, DECK, DV, EDR, EMN, EXPE, IM, INFA, KFN, KLAC, MXIM, MXWL, N, OLN, PFG, PWER, QLIK, RGC, SPF, VAR, VRSN, WRE, WWWW 2 Comments [Earnings]
- Wednesday, October 24, 2012, 5:35 PM Notable earnings after Thursday’s close: AAPL, AMZN, APKT, BAS, BMRN, CA, CB, CERN, CINF, CLD, CLWR, COG, CRBC, CSTR, DECK, DV, EDR, EMN, EXPE, IM, INFA, KFN, KLAC, MXIM, MXWL, N, OLN, PFG, PWER, QLIK, RGC, SPF, VAR, VRSN, WRE, WWWW 1 Comment [Earnings]
- Saturday, September 15, 2012, 9:00 AM Healthcare stocks may face some income squeezes in coming years regardless of political outcomes, but there are still bargains to be had - if you look at healthcare's overall cost-cutters, and keep an eye on valuation. Dividend payers like Merck (MRK) and Pfizer (PFE) already reflect coming cost pressure, while innovators like Varian (VAR) or Perrigo (PRGO) come at cheaper valuations than firms like Intuitive Surgical (ISRG). Comment! [Healthcare, Quick Ideas]
-
StockViews
GS upgrade $VAR to NEUTRAL. "we see business fundamentals stabilising and consensus estimates now look reasonable" - View all 0 replies
-
The Oxen Group
Go long in VAR based on analysis done of the past 10 years going into and out of July earnings. http://stks.co/j2OI - View all 0 replies
-
Jim Van Meerten
VAR - 60% Barchart technical sell signal - 9.40% off its 1 year high - Relative Strength Index 40.75% - View all 0 replies
LATEST REPLIES



